Dr Ahmad Izuanuddin Ismail is a Consultant Respiratory Physician & Senior Lecturer Respiratory Medicine and is now Deputy Dean (Clinical Service) in Faculty of Medicine UiTM Sungai Buloh / Selayang / Teluk Intan. He graduated from University College Dublin in 2002. He obtained his Membership of Royal College of Physicians of Ireland in 2007 and embarked on training in Respiratory Medicine in Ireland. He joined the Faculty of Medicine upon returning to Malaysia in 2010. He completed his Fellowship training in Respiratory Medicine in 2012.

Dr Izuan enjoys his football during his free time and a big fan of Manchester United. He is a member of European Respiratory Society (ERS), Asian Pacific Society of Respirology (APSR), Malaysian and Irish Thoracic Societies, and Sleep Disorder Society Malaysia (SDSM). His main interests are Sleep Medicine and Interventional Pulmonology. He was awarded with Fellowship of American College of Chest Physician (FCCP) in 2013.


Development and Validation of Malay Version Epworth Sleepiness Scale

Principal investigator; Dana Kecemerlangan UiTM

CQMF149F2202 Study

A randomized, double-blind, 12-week treatment, parallel group study to evaluate the efficacy and safety of QMF149 (150 μg/160 μg o.d.) compared with salmeterol xinafoate/fluticasone propionate (50 μg/500 μg b.i.d.) in patients with chronic obstructive pulmonary disease

Principal Investigator – International Grant

Relative Lung Bioavailability and Lung Deposition of inhaled Salbutamol via Metered Dose Inhaler (MDI) Attached to a Spacer, Jet and Ultrasonic Nebuliser in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients: in vitro and in vivo

Risk factors for recurrent exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

SAS 115359 Study

A safety and efficacy study of inhaled Fluticasone Propionate/Salmeterol combination versus inhaled Fluticasone Propionate in the treatment of adolescent and adult subjects with persistent asthma

BREATH 3085 Study

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0mg/kg) as Treatment for Patients with Eosinophilic Asthma Who Completed a Prior Cephalon-Sponsored Study in Eosinophilic Asthma


A 52-week, double blind, randomized, placebo controlled parallel group study to evaluate the effect of Roflumilast 500µg on exacerbation rate in subjects with chronic obstructive pulmonary disease (COPD) treated with a fixed dose combination of long-acting beta agonist and inhaled corticosteroid (LABA/ICS)

A Phase III, multicenter, international, randomised, parallel group, double blind cardiovascular safety study of BI10773 (10mg and 25mg administered once daily) compared to usual care in type 2 diabetes mellitus patients with increased cardiovascular risk

A randomised, active-controlled, double-blind, double-dummy, parallel group design, multi-center trial to compare the efficacy and safety of 2.5 µg and 5 µg Tiotropium Inhalation Solution delivered by the Respimat® Inhaler with Tiotropium inhalation capsules 18 µg delivered by the HandiHaler®

BREATH 3082 Study

A 12-month, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of Reslizumab (3.0 mg/kg) in the reduction of clinical asthma exacerbations and change in lung function in patients (12-75 years of age) with eosinophilic asthma


  • AI Ismail, et al 2012, Rate of Lung Function Decline in Rural Urban Study of Malaysian Population. Respirology, 17(Suppl. 2): 123
  • AI Ismail, et al 2012, Cardiometabolic Co-Morbidities in Patients with OSA Attending Multidisciplinary Sleep Clinic. Respirology, 17(Suppl. 2): 119
  • AI Ismail, et al 2012, Heart Rate Variability Correlates with Severity of Obstructive Sleep Apnoea. Sleep and Biological Rhythms, 10: 67-68
  • MA Abd Rahman, NS Bakar, …, AI Ismail 2012, Clinical Correlation of EGFR Protein Overexpression with Histological Growth Pattern: A Preliminary Pattern. Respirology, 17(Suppl. 2): 97
  • SH How, R Rajalingam, YC Kuan, A Norazah, AI Ismail, et al 2012, Fatal Pneumonia Following Search and Rescue Operation. Respirology, 17(Suppl. 2): 106